Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic review and meta-analysis

BACKGROUND: Glucagon-like peptide (GLP-1) analogues are a new class of drugs used in the treatment of type 2 diabetes. They are given by injection, and regulate glucose levels by stimulating glucose-dependent insulin secretion and biosynthesis, suppressing glucagon secretion, and delaying gastric em...

Descripción completa

Detalles Bibliográficos
Autores principales: Shyangdan, Deepson S, Royle, Pamela L, Clar, Christine, Sharma, Pawana, Waugh, Norman R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017518/
https://www.ncbi.nlm.nih.gov/pubmed/21143938
http://dx.doi.org/10.1186/1472-6823-10-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017518/
https://www.ncbi.nlm.nih.gov/pubmed/21143938
http://dx.doi.org/10.1186/1472-6823-10-20

Ejemplares similares